Mediterranean Journal of Hematology and Infectious Diseases

REVIEW ARTICLES

TREATMENT OF INDOLENT AND ADVANCED SYSTEMIC MASTOCYTOSIS

Dr. Alessandro Buonomo, Dr. Eleonora Nucera, Dr. Marianna Criscuolo

DOI https://doi.org/10.4084/MJHID.2022.040 Page e2022040 PDF HTML

DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES

Prof. Giuseppe Leone, Dr. Emiliano Fabiani, Prof. Maria Teresa Voso

DOI https://doi.org/10.4084/MJHID.2022.030 Page e2022030 PDF HTML

HAS HEMATOPOIETIC STEM CELL TRANSPLANTATION A ROLE IN THE TREATMENT OF CHILDREN AND ADOLESCENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA?

Anna Maria Testi

DOI https://doi.org/10.4084/MJHID.2022.038 Page e2022038 PDF HTML

ORIGINAL ARTICLES

EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA

Cumali Yalçın, Fahir Özkalemkaş, Vildan Özkocaman, Tuba Ersal, İbrahim Ethem Pınar, Bedrettin Orhan, Ömer Candar, Sinem Çubukçu, Tuba Güllü Koca, Merve Nur Akyol, Nevriye Gül Ada, Cüneyt Özakın, Esra Kazak, Halis Akalın, Rıdvan Ali

DOI https://doi.org/10.4084/MJHID.2022.039 Page e2022039 PDF HTML

REAL WORLD MULTIPLE MYELOMA REGISTRY FROM JORDAN, A DEVELOPING COUNTRY.

Abdalla Awidi, Farah Qasem, A'sem Abu-Qamar, Batool Aqel, Rand Aladayleh, Ilham Alteerah, Ahmad Magableh, , Hisham Bawa”neh, Feras Al-fararjeh

DOI https://doi.org/10.4084/MJHID.2022.031 Page e2022031 PDF HTML

The IMPACT OF SUPEROXIDE DISMUTASE GENETIC POLYMORPHISM (SOD2 VAL16ALA) AND SUPEROXIDE DISMUTASE LEVEL ON DISEASE SEVERITY IN A COHORT OF EGYPTIAN SICKLE CELL DISEASE PATIENTS IN EGYPT

Mervat Khorshied, Iman A, Shaheen, Yasmeen M.M Selim, Asmaa O. Elshahawy, Ilham Youssry

DOI https://doi.org/10.4084/MJHID.2022.037 Page e2022037 PDF HTML

EPIDEMIOLOGICAL AND CLINICAL CHARACTERISTICS OF PEDIATRIC COVID-19 IN THE TERTIARY CARE SYSTEM IN THAILAND: COMPARATIVE DELTA AND PRE-DELTA ERA

Araya Satdhabudha, Chanapai Chaiyakulsil, Paskorn Sritipsukho, Phakatip Sinlapamongkolkul, Utairat Chaumrattanakul, Auchara Tangsathapornpong, Pornumpa Bunjoungmanee, Patcharapa Thaweekula, Amolchaya Kwankuac, Onsuthi Pharadornuwata, Tananya Lokanuwatsatiena, Pichaya Tantiyavarongd, Pakarat Pranudomrata, Chatchai Mingmalairake

DOI https://doi.org/10.4084/MJHID.2022.044 Page e2022044 PDF HTML

COMPARISON OF EMPIRIC ANTIBIOTIC ESCALATION THERAPY WITH VANCOMYCIN (VAN) VERSUS LINEZOLID (LIN) IN PATIENTS WITH FEBRILE NEUTROPENIA

Karin Mayer, Nicolaus Hegge, Ernst Molitor, Peter Brossart, Corinna Hahn-Ast

DOI https://doi.org/10.4084/MJHID.2022.032 Page e2022032 PDF HTML

ENDOTHELIAL BIOMARKERS IN PATIENTS RECOVERED FROM COVID-19 ONE YEAR AFTER HOSPITAL DISCHARGE: A CROSS-SECTIONAL STUDY

Ming Tong, Xiquan Yan, Yu Jiang, Zhaoxia Jin, Shengjiao Zhu, Lianhong Zou, Yanjuan Liu, Qing Zheng, Guoqiang Chen, Ruifeng Gui Gui, Zhilan Zhou, Xiaotong Han, Jiangming He, Siqing Yin, Changchun Ma, Wen Xiao, Yong Zeng, Fang Chen, Yimin Zhu

DOI https://doi.org/10.4084/MJHID.2022.033 Page e2022033 PDF HTML

THE CLINICAL SIGNIFICANCE OF THE SPECTRUM OF INTERACTIONS OF THE RARE IVS-II-5 G>C (HBB: C.315+5 G>C) VARIATION WITH OTHER Β-THALASSEMIA MUTATIONS IN SOUTHERN CHINA

Yali Zhou, Guiping Liao, Xiaolin Yin, Sheng He, Yi Wu, Jian Xiao, Zhili Geng, Qiuying Huang, Ganghui Luo, Kun Yang

DOI https://doi.org/10.4084/MJHID.2022.034 Page e2022034 PDF HTML

ASSOCIATION BETWEEN HEPARIN DOSE AND 6-WEEKS MORTALITY IN PATIENTS WITH COVID-19

Claire Coutureau, Philippe Nguyen, Maxime Hentzien, Peter Joe Noujaim, Sarah Zerbib, Damien Jolly, Lukshe Kanagaratnam

DOI https://doi.org/10.4084/MJHID.2022.036 Page e2022036 PDF HTML

CASE REPORTS

The venetoclax/azacitidine combination targets the disease clone in Acute Myeloid Leukemia, being effective and safe in a patient with COVID

Antonio Cristiano, Raffaele Palmieri, Emiliano Fabiani, Tiziana Ottone, Mariadomenica Divona, Arianna Savi, Francesco Buccisano, Luca Maurillo, Corrado Tarella, William Arcese, Maria Teresa Voso

DOI https://doi.org/10.4084/MJHID.2022.041 Page e2022041 PDF HTML

Managment of Relapsed/Refractory ALL With Inotuzumab During COVID-19. A Casr Report

Martina Di Palma, Elio Gentilini, Chiara Masucci, Alessandra Micozzi, Ombretta Turriziani, Antonino Mulè, Robin Foà, Maurizio Martelli, Gabriella D'Ettorre, Saveria Capria, Sabina Chiaretti

DOI https://doi.org/10.4084/MJHID.2022.043 Page e2022043 PDF HTML

LETTERS TO THE EDITOR

Post-therapy B regulatory cells might early predict relapse in Hodgkin lymphoma

Valentina Giudice, Luca Pezzullo, Giuseppe Ciancia, Matteo D'Addona, Francesca D'Alto, Marisa Gorrese, Bianca Cuffa, Carmine Selleri

DOI https://doi.org/10.4084/MJHID.2022.042 Page e2022042 PDF HTML

The Mediterranean Journal of Hematology and Infectious Diseases: A New Milestone and a Hope for Researchers in Third World Countries

Nawfal R Hussein

DOI https://doi.org/10.4084/MJHID.2022.035 PDF HTML

Ixazomib-associated skin exfoliation Yali Zhang, Long Zhao, Yuancheng Guo, bei liu DOI https://doi.org/10.4084/MJHID.2022.045 Page e2022045 PDF HTML